|
Mera Pharmaceuticals, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Mera Pharmaceuticals, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Mera Pharmaceuticals, Inc.. The Company's principal activities are to develop and commercialize natural products from microalgae using the large-scale photobioreactor technology known as Mera Growth Module (MGM). Its three operations are Natural Products,Contract services and Royalties. It uses its photobioreactor technology in the production and marketing of its first commercial product, ASTAFACTOR(R), a nutraceutical & source of natural astaxanthin. Its Trademarks & Service marks are SALMONESSENTIALS, AQUAXAN, MERA PHARMACEUTICALS, MERA GROWTH MODULE, MERA PROCESS CONTROL SYSTEM, MERA REMOTE DATA WEB ACCESS & DRUGS FROM THE SEA. The microalgae are known to contain valuable substances that have existing & potential commercial applications in fields such as animal and human nutrition, food colorings, cosmetics, diagnostic products, pharmaceuticals, research grade chemicals, pigments & dyes. It operates in the United States, Korea & Malaysia.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
